Project Grants in Clinical and Translational Medicine
Supports innovative Danish clinical and translational research, with a focus on the interplay between infectious and cardiometabolic diseases to improve patient care and public health.
Funder: Novo Nordisk Foundation
Due Dates: August 19, 2026: Full application submission deadline
Funding Amounts: Up to DKK 4.5 million per project (1–3 years); total program budget DKK 76 million; DKK 13.5 million earmarked for infectious and cardiometabolic disease projects
Summary: Supports innovative Danish clinical and translational research, with special emphasis on the interplay between infectious diseases and cardiometabolic diseases.
Key Information: Only experienced independent researchers at Danish universities, hospitals, or non-profit research institutions may apply; main applicant salary cannot be covered.
Description
This grant program aims to advance high-level Danish clinical and translational research, focusing on projects involving patients, clinical practice, diagnostic or therapeutic methods, and established animal models. Special priority is given to research exploring the interactions between infectious diseases and cardiometabolic diseases, reflecting their complex and significant impact on public health. The Novo Nordisk Foundation seeks to fund innovative projects that enhance understanding or practice in clinical and translational medicine, with a strong emphasis on societal and scientific impact.
